Later, the study evaluated if IP1 and or IP2 are effective in reducing cardio-metabolic risk factors, increasing knowledge on T2DM and affecting attitudes towards T2DM prevention measures, as compared to a baseline (pre-post analysis). This evidence concerns the gene IKBKG and type 2 diabetes mellitus.